-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
- BioNexus Gene Lab Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.34M, a 47.1% increase year-over-year.
- BioNexus Gene Lab Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$900K, a 69.7% increase year-over-year.
- BioNexus Gene Lab Corp annual Operating Income (Loss) for 2023 was -$2.59M, a 791% decline from 2022.
- BioNexus Gene Lab Corp annual Operating Income (Loss) for 2022 was -$291K, a 128% decline from 2021.
- BioNexus Gene Lab Corp annual Operating Income (Loss) for 2021 was $1.06M, a 17.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)